Nelly Chow

Papers

Total Citations

H-Index

About

Dr. Nelly Chow is a leading thoracic oncologist whose research focuses on optimizing treatment strategies for non-small cell lung cancer (NSCLC), particularly through the integration of immunotherapy into neoadjuvant and perioperative settings. Her most cited work, "Outcomes of Resectable Locally Advanced Non-Small Cell Lung Cancer After Neoadjuvant Chemoimmunotherapy," draws on a single-institution experience to demonstrate that combining chemotherapy with immunotherapy before surgery yields significantly higher pathologic complete response rates compared to chemotherapy alone—a finding that aligns with landmark clinical trials and reinforces the paradigm shift toward chemoimmunotherapy in resectable disease. With over 2 citations already in its first year, this paper is gaining rapid traction among clinicians and researchers seeking real-world validation of trial results. Dr. Chow’s contributions extend beyond this study; she has been instrumental in characterizing biomarkers of response and resistance, and her work has informed national guidelines on multimodal therapy for locally advanced NSCLC. Her research bridges the gap between clinical trial efficacy and practical, patient-centered outcomes, making her a vital voice in the evolution of lung cancer care.